Nikkei 225 Replacement of Toshiba - A Closer Look
About a week and a half ago, just after the TSE announced the demotion of Toshiba Corp (6502 JP) from the TSE's first section effective August 1st,...
739 Views
Medrx - Japan Biotech Microcap in Potential Big Licensing Deal
Although the Japanese drug industry suffers from a lack of scale, where it is good is in applying manufacturing techniques to develop not just...
614 Views
PeptiDream: J&J Latest Drug Major to Tie Up
On the surface, Peptidream's (4587 JP) deal with Johnson & Johnson's (JNJ US) Janssen unit looks no different from the deals they have cut with...
489 Views
Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
405 Views